<SEC-DOCUMENT>0001104659-25-058542.txt : 20250611
<SEC-HEADER>0001104659-25-058542.hdr.sgml : 20250611
<ACCEPTANCE-DATETIME>20250611161529
ACCESSION NUMBER:		0001104659-25-058542
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250611
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250611
DATE AS OF CHANGE:		20250611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Astrana Health, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		251040186

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Apollo Medical Holdings, Inc.
		DATE OF NAME CHANGE:	20080715

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2517571d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ASTH="http://apollomed.net/20250611">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_ASTH_apollomed.net_20250611 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20250611_20250611 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001083446 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000004" name="dei:EntityCentralIndexKey">0001083446</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="asth-20250611.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-11</xbrli:startDate>
        <xbrli:endDate>2025-06-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_908_edei--DocumentType_c20250611__20250611_zGQXUsLfobh2"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)
of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event
reported): <b><span id="xdx_90C_edei--DocumentPeriodEndDate_c20250611__20250611_zAAIw6Io0cbh"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 11, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20250611__20250611_zHwJodmjrOgc"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000011" name="dei:EntityRegistrantName">ASTRANA HEALTH, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20250611__20250611_zY3Na739Roq1"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityFileNumber_c20250611__20250611_zqvjhJj7znWi"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000013" name="dei:EntityFileNumber">001-37392</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20250611__20250611_zj2mnqxba9S8"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000014" name="dei:EntityTaxIdentificationNumber">95-4472349</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission </span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20250611__20250611_zZSbqW5xhw9f"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000015" name="dei:EntityAddressAddressLine1">1668 S. Garfield Avenue</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20250611__20250611_zg11UGoMXgp6"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000016" name="dei:EntityAddressAddressLine2">2nd Floor</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressCityOrTown_c20250611__20250611_zy4xxQNSaf99"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000017" name="dei:EntityAddressCityOrTown">Alhambra</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20250611__20250611_z75tbGGaiLkc"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20250611__20250611_zy3uBEH4kUJa"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000019" name="dei:EntityAddressPostalZipCode">91801</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_902_edei--CityAreaCode_c20250611__20250611_zubVV6nlshW8"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000020" name="dei:CityAreaCode">626</ix:nonNumeric></span>) <span id="xdx_909_edei--LocalPhoneNumber_c20250611__20250611_zqM6VOnVrunl"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000021" name="dei:LocalPhoneNumber">282-0288</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s Telephone Number, Including
Area Code</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed Since
Last Report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_909_edei--WrittenCommunications_c20250611__20250611_z2jpTclhD8Pb"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20250611__20250611_z436quFZQtpa"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementTenderOffer_c20250611__20250611_zjAT7oClHgYf"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20250611__20250611_zRmKLv5mBHr5"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border: Black 1pt solid; vertical-align: bottom; width: 36%; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><b>Title
    of each class</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 30%; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><b>Trading
    symbol(s)</b></td>
    <td style="border: Black 1pt solid; vertical-align: bottom; width: 34%; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><b>Name
    of each exchange on which registered</b></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><span id="xdx_909_edei--Security12bTitle_c20250611__20250611_zVr5rE8fF0gj"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.001 par value per share</ix:nonNumeric></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><span id="xdx_904_edei--TradingSymbol_c20250611__20250611_zKho68HMMEU9"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000027" name="dei:TradingSymbol">ASTH</ix:nonNumeric></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: center">The <span id="xdx_90E_edei--SecurityExchangeName_c20250611__20250611_zLdjjXTKHWH2"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Stock Market LLC</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Emerging growth company&#160;</span><span style="font-family: Wingdings"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20250611__20250611_zdnXfI9pIg5d"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 5.02</b></td><td style="text-align: justify"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers. </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The stockholders of Astrana Health, Inc. (the
&#8220;Company&#8221;) approved the Astrana Health,&#8239;Inc. Amended and Restated 2024 Equity Incentive Plan (the &#8220;2024 Plan&#8221;)
at the 2025 Annual Meeting of Stockholders of the Company (the &#8220;Annual Meeting&#8221;) held on June 11, 2025. The 2024 Plan was
previously approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). As amended and restated, the number of shares
of the Company&#8217;s common stock reserved for issuance under the 2024 Plan has been increased by 2,000,000 shares and the term of the
2024 Plan has been extended until March&#8239;25, 2035.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A summary of the 2024
Plan is included in <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1083446/000110465925039438/tm252605d1_def14a.htm#def14a_009" style="-sec-extract: exhibit">Proposal 4</a> of the Company&#8217;s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 25,
2025 (the &#8220;Proxy Statement&#8221;), which summary is incorporated in its entirety herein by reference. The summaries of the 2024
Plan contained herein and in the Proxy Statement do not purport to be complete and are subject to, and qualified in their entirety by
reference to, the full text of the 2024 Plan, a copy of which is filed as <span style="background-color: White"><a href="tm2517571d1_ex10-1.htm" style="-sec-extract: exhibit">Exhibit
10.1</a></span> to this Current Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 5.07</b></td><td><b>Submission of Matters to a Vote of Security Holders. </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company held its
Annual Meeting on June 11, 2025. At the close of business on April&#8239;22, 2025, the record date for the Annual Meeting (the &#8220;Record
Date&#8221;), there were 56,072,504 shares of common stock, par value $0.001 per share, of the Company issued and outstanding. At the
Annual Meeting, there were present in person or by proxy 42,924,341 shares of the Company&#8217;s common stock, representing stockholders
entitled to cast approximately 76.6% of the total outstanding eligible votes and constituting a quorum. At the Annual Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">1.</td><td>Nine directors were elected to the Board, each to hold office until the 2026 Annual Meeting of Stockholders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">The appointment of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year
ending December 31, 2025 was ratified.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">3.</td><td style="text-align: justify">The compensation program for the Company&#8217;s named executive officers as disclosed in Proxy Statement was approved, on an advisory,
non-binding basis.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">4.</td><td>The 2024 Plan was approved.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The voting results for each such matter were
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 1. Election of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 37%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominee</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Withheld</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kenneth Sim, M.D.</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,349,403</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">824,810</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas S. Lam, M.D., M.P.H.</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,495,131</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">679,082</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mitchell W. Kitayama</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,450,798</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">723,415</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David G. Schmidt</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,537,039</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">637,174</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linda Marsh</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,093,426</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,080,787</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Chiang</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,771,282</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">402,931</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew Mazdyasni</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,751,167</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">423,046</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J. Lorraine Estradas, R.N., B.S.N. M.P.H.</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,151,998</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,022,215</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weili Dai</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,977,644</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,196,569</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 2. Ratification of Appointment
of Independent Registered Public Accounting Firm</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 27%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,631,420</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,880</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,041</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 3. Advisory Vote on Executive
Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 27%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,713,926</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,370,998</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,289</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 4. Approval of the 2024 Plan </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 27%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,772,471</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,245,886</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155,856</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,750,128</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 9.01</b></td><td><b>Financial Statements and Exhibits. </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>Exhibit No.</b></td>
    <td>&#160;</td>
    <td style="text-align: center"><b>Description of Exhibit</b></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="border-top: black 1pt solid; vertical-align: top; text-align: center"><a href="tm2517571d1_ex10-1.htm" style="-sec-extract: exhibit">10.1*</a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-top: black 1pt solid; vertical-align: bottom"><a href="tm2517571d1_ex10-1.htm" style="-sec-extract: exhibit">Astrana Health,&#8239;Inc. Amended and Restated 2024 Equity Incentive Plan.</a></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">104</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Management contract or compensatory plan, contract or arrangement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom"><b>ASTRANA HEALTH, INC.</b></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 50%">Date: June 11, 2025</td>
    <td style="vertical-align: bottom; width: 5%">By: </td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 45%">/s/ Brandon K. Sim</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">Name:</td>
    <td style="vertical-align: bottom">Brandon K. Sim</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">Title:</td>
    <td style="vertical-align: bottom">Chief Executive Officer and President</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fo3xD/toqUWsIkXE12BXCbbZsol/R/KWxhZxWViWmW9GiJ7IaGkqZDguihz2WDeV9ggFnpHRnjA4ktU6hnALvBjnWVvfvj8wocBgYCZ9pU5BaK1347CMQc4GajRQY5DzWE5htxHRV0/Ink2J1htdgbYl7JgaNug1v7qEvX6SpfrVVh2QnSEbw7AvO/kNSg4VbOmuH8RXB3meiKjXTiQyplsTXOnTo/2SkFZYhzrX0f+NPgvOSpU= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2517571d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0px; background-color: rgb(255, 255, 255)"><B>ASTRANA
HEALTH,&#8239;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-align: center; text-indent: 0px; background-color: rgb(255, 255, 255)"><B>AMENDED AND RESTATED 2024 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="text-align: center; color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Establishment,
Purpose, Duration.</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Establishment</U>.
Astrana Health,&#8239;Inc. (the &ldquo;<U>Company</U>&rdquo;) originally established the Astrana Health,&#8239;Inc. 2024 Equity Incentive
Plan, effective as of February&#8239;28, 2024 (the &ldquo;<U>Effective Date</U>&rdquo;), subject to the approval of the Plan by the stockholders
of the Company at the 2024 Annual Meeting of Stockholders. The Plan is hereby amended and restated in its entirety as set forth herein,
effective as of March&#8239;26, 2025 (the &ldquo;<U>Restatement Date</U>&rdquo;), subject to approval of the amended and restated Plan
by the stockholders of the Company at the 2025 Annual Meeting of Stockholders. Definitions of certain capitalized terms used in the Plan
are contained in Section&#8239;2 hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Purpose</U>.
The purpose of the Plan is to attract and retain Directors, Consultants, officers and other key Employees of the Company and its Subsidiaries,
and to provide to such persons incentives and rewards for superior performance.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Duration</U>.
No Award may be granted under the Plan on or after the tenth (10th) anniversary of the Restatement Date, or such earlier date as the Board
shall determine. The Plan will remain in effect with respect to outstanding Awards until no Awards remain outstanding.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Termination
of 2015 Plan</U>. The Company&rsquo;s 2015 Equity Incentive Plan (the &ldquo;<U>2015 Plan</U>&rdquo;) terminated in its entirety effective
upon stockholder approval of the Plan, and no further awards may be granted under the 2015 Plan thereafter; provided that all outstanding
awards under the 2015 Plan as of the date of the 2024 Annual Meeting of Stockholders shall remain outstanding and shall be administered
and settled in accordance with their terms and the provisions of the 2015 Plan.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Definitions.</B>&nbsp;As
used in the Plan, the following definitions shall apply.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Applicable
Laws</U>&rdquo; means the applicable requirements relating to the administration of equity-based compensation plans under U.S. state corporate
laws, U.S. federal and state securities laws, the Code, the rules&#8239;of any stock exchange or quotation system on which the Shares
are listed or quoted and the applicable laws of any other country or jurisdiction where Awards are granted or administered or in which
Participants work or reside.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Award</U>&rdquo;
means an award of Nonqualified Stock Options,&#8239;Incentive Stock Options, Stock Appreciation Rights, Restricted Shares, Restricted
Share Units or Other Share-Based Awards granted pursuant to the terms and conditions of the Plan.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Award
Agreement</U>&rdquo; means either: (i)&#8239;an agreement, in written or electronic format, entered into by the Company and a Participant
setting forth the terms and provisions applicable to an Award granted under the Plan; or (ii)&#8239;a statement, in written or electronic
format, issued by the Company to a Participant describing the terms and provisions of such Award, which need not be signed by the Participant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Beneficial
Owner</U>&rdquo; shall have the meaning ascribed to such term in Rule&#8239;13d-3 under the Exchange Act and any successor to such Rule.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Board</U>&rdquo;
means the Board of Directors of the Company.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Cause</U>&rdquo;
as a reason for the Company&rsquo;s (or a Subsidiary&rsquo;s) termination of a Participant&rsquo;s Continuous Service shall have the meaning
specified in the applicable Award Agreement. In the absence of any definition in the Award Agreement, &ldquo;<U>Cause</U>&rdquo; shall
have the equivalent meaning or the same meaning as &ldquo;cause&rdquo; or &ldquo;for cause&rdquo; set forth in any employment, consulting,
or other agreement for the performance of services between the Participant and the Company or a Subsidiary or, in the absence of any such
agreement that defines the term, &ldquo;<U>Cause</U>&rdquo; shall mean: (i)&#8239;conduct by the Participant constituting a material act
of willful misconduct in connection with the performance of the Participant&rsquo;s duties that results in loss, damage or injury that
is material to the Company or a Subsidiary; (ii)&#8239;the commission by the Participant of any felony; (iii)&#8239;continued, willful
and deliberate non-performance by the Participant of the Participant&rsquo;s duties to the Company or a Subsidiary (other than by reason
of the Participant&rsquo;s physical or mental illness, incapacity or disability); (iv)&#8239;Participant&rsquo;s material breach of any
employment agreement, consulting agreement or agreement regarding nondisclosure of confidential information that results in loss, damage
or injury that is material to the Company or a Subsidiary; (v)&#8239;willful failure to cooperate with a bona fide internal investigation
or an investigation by regulatory or law enforcement authorities, after being instructed by the Company or a Subsidiary to cooperate,
or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the willful
inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigations; or (vi)&#8239;fraud,
embezzlement or theft against the Company or any of its Subsidiaries or affiliates. With respect to the events in (i), (iii)&#8239;and
(iv)&#8239;herein, the Company or a Subsidiary shall have delivered written notice to the Participant of its intention to terminate the
Participant&rsquo;s employment or other service for Cause, which notice specifies in reasonable detail the circumstances claimed to give
rise to the Company&rsquo;s (or Subsidiary&rsquo;s) right to terminate the Participant&rsquo;s employment or other service for Cause and
the Participant shall not have cured such circumstances to the extent such circumstances are reasonably susceptible to cure, as determined
by the Company (or Subsidiary) in good faith, within thirty (30) days following the delivery of such notice to the Participant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Change
of Control</U>&rdquo; shall mean, unless otherwise specified in an Award Agreement, the occurrence of any of the following:</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Any
Person becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 50% or more of the total voting
power represented by the Company&rsquo;s then outstanding voting securities (excluding for this purpose any such voting securities held
by the Company or its Subsidiaries or by any employee benefit plan of the Company or a Subsidiary) pursuant to a transaction or a series
of related transactions; or</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
closing of either (A)&#8239;A merger or consolidation of the Company whether or not approved by the Board, other than a merger or consolidation
which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into voting securities of the surviving entity or the parent of such corporation) more than 50% of the
total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation, as the
case may be, outstanding immediately after such merger or consolidation; or (B)&#8239;the sale or disposition by the Company of all or
substantially all of the Company&rsquo;s assets; or</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>A
change in the composition of the Board of Directors, as a result of which fewer than a majority of the directors are Incumbent Directors.
For this purpose, &ldquo;<U>Incumbent Directors</U>&rdquo; shall mean members of the Board who either (A)&#8239;are directors of the&#8239;Company
on the date twenty-four (24) months prior to the date of the event that may constitute a Change of Control, or (B)&#8239;are elected,
or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such
election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened
proxy contest relating to the election of directors to the Company).</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended, and any regulations promulgated and in effect thereunder.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Committee</U>&rdquo;
means the Board&rsquo;s Compensation Committee or such other committee or subcommittee of the Board as may be duly appointed to administer
the Plan, and having such powers in each instance as shall be specified by the Board. To the extent required by Applicable Laws, the Committee
shall consist of two or more members of the Board, each of whom is a &ldquo;non-employee director&rdquo; within the meaning of Rule&#8239;16b-3
promulgated under the Exchange Act and an &ldquo;independent director&rdquo; within the meaning of applicable rules&#8239;of any securities
exchange upon which Shares are listed.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Company</U>&rdquo;
means Astrana Health,&#8239;Inc., a Delaware corporation (formerly known as Apollo Medical Holdings,&#8239;Inc.), and any successor thereto.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Consultant</U>&rdquo;
means an independent contractor who (i)&#8239;performs services for the Company or a Subsidiary in a capacity other than as an Employee
or Director, and (ii)&#8239;qualifies as a consultant under the applicable rules&#8239;of the SEC for registration of shares on a Form&#8239;S-8
Registration Statement.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Continuous
Service</U>&rdquo; means the uninterrupted provision of services to the Company or any Subsidiary in any capacity of Employee, Director,
or Consultant. Continuous Service shall not be considered to be interrupted in the case of (i)&#8239;any approved leave of absence; (ii)&#8239;transfers
among the Company, any Subsidiaries, or any successor entities, in any capacity of Employee, Director or Consultant; or (iii)&#8239;any
change in status as long as the individual remains in the service of the Company, a Subsidiary, or successor of either in any capacity
of Employee, Director or Consultant (except as otherwise provided in such individual&rsquo;s Award Agreement). An approved leave of absence
shall include sick leave, military leave, or any other authorized personal leave.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Date
of Grant</U>&rdquo; means the date specified by the Committee on which the grant of an Award is to be effective. The Date of Grant shall
not be earlier than the date of the resolution and action therein by the Committee to grant such Award. In no event shall the Date of
Grant be earlier than the Effective Date.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Director</U>&rdquo;
means any individual who is a member of the Board and who is not an Employee.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Effective
Date</U>&rdquo; has the meaning given such term in Section&#8239;1(a)&#8239;hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Employee</U>&rdquo;
means any employee of the Company or a Subsidiary; provided, however, that for purposes of determining whether any person may be a Participant
for purposes of any grant of Incentive Stock Options, the term &ldquo;Employee&rdquo; has the meaning given to such term in Section&#8239;3401(c)&#8239;of
the Code, as interpreted by the regulations thereunder and Applicable Laws.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934 and the rules&#8239;and regulations promulgated and in effect thereunder, as
such law, rules, and regulations may be amended from time to time.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Fair
Market Value</U>&rdquo; means the value of one Share on any relevant date, determined under the following rules: (i)&#8239;the closing
sale price per Share on that date as reported on the Nasdaq Stock Market or such other principal exchange on which Shares are then trading,
if any, or if there are no sales on that date, on the next preceding trading day during which a sale occurred; (ii)&#8239;if the Shares
are not reported on a principal exchange or national market system, the average of the closing bid and asked prices last quoted on that
date by an established quotation service for over-the-counter securities; or (iii)&#8239;if neither (i)&#8239;nor (ii)&#8239;applies,
(A)&#8239;with respect to Stock Options, Stock Appreciation Rights and any Award of stock rights that is subject to Section&#8239;409A
of the Code, the value as determined by the Committee through the reasonable application of a reasonable valuation method, taking into
account all information material to the value of the Company, within the meaning of Section&#8239;409A of the Code, and (B)&#8239;with
respect to all other Awards, the fair market value as determined by the Committee in good faith.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Good
Reason</U>&rdquo; shall, with respect to any Participant, have the meaning (if any) specified in the applicable Award Agreement, or, in
the absence of any definition in the Award Agreement, &ldquo;<U>Good Reason</U>&rdquo; shall have the equivalent meaning or the same meaning
(if any) as &ldquo;good reason&rdquo; or &ldquo;for good reason&rdquo; set forth in an applicable employment, consulting or other agreement
for the performance of services between the Participant and the Company or a Subsidiary, if any, that defines such term. For purposes
of clarity, a Participant shall have no rights under this Plan with respect to termination for &ldquo;Good Reason&rdquo; unless and to
the extent that such Participant is a party to an applicable Award Agreement, employment agreement, consulting agreement or other agreement
for the performance of services between the Participant and the Company or a Subsidiary that defines the term &ldquo;Good Reason&rdquo;
with respect to such Participant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Incentive
Stock Option</U>&rdquo; or &ldquo;<U>ISO</U>&rdquo; means a Stock Option that is designated as an Incentive Stock Option and that is intended
to meet the requirements of Section&#8239;422 of the Code.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Nonqualified
Stock Option</U>&rdquo; means a Stock Option that is not intended to meet the requirements of Section&#8239;422 of the Code or otherwise
does not meet such requirements.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Other
Share-Based Award</U>&rdquo; means an equity-based or equity-related Award not otherwise described by the terms of the Plan, granted in
accordance with the terms and conditions set forth in Section&#8239;10 hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Participant</U>&rdquo;
means any eligible individual as set forth in Section&#8239;5 who holds one or more outstanding Awards.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Performance
Award</U>&rdquo; has the meaning given such term in Section&#8239;14(a).</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Performance
Objectives</U>&rdquo; means the performance objective or objectives that may be established by the Committee with respect to an Award
granted pursuant to the Plan. Any Performance Objectives may relate to the performance of the Company or one or more of its Subsidiaries,
divisions, departments, units, functions, partnerships, joint ventures or minority investments, product lines or products, or the performance
of the individual Participant, and may include, without limitation, the Performance Objectives listed in Section&#8239;14(a). The Performance
Objectives may be made relative to the performance of a group of comparable companies, or a published or special index that the Committee,
in its sole discretion, deems appropriate, or the Company may select Performance Objectives as compared to various stock market indices.
Performance Objectives may be stated as a combination of such factors. Any Performance Objectives that are financial metrics may be determined
in accordance with United States Generally Accepted Accounting Principles (&ldquo;<U>GAAP</U>&rdquo;), if applicable, or may be adjusted
when established to include or exclude any items otherwise includable or excludable under GAAP.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Person</U>&rdquo;
shall have the meaning ascribed to such term in Section&#8239;3(a)(9)&#8239;of the Exchange Act and used in Sections 13(d)&#8239;and 14(d)&#8239;thereof,
and shall include a &ldquo;group&rdquo; as defined in Section&#8239;13(d)&#8239;thereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Plan</U>&rdquo;
means this Astrana Health,&#8239;Inc. Amended and Restated 2024 Equity Incentive Plan, as amended from time to time.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Qualified
Termination</U>&rdquo; means any termination of a Participant&rsquo;s Continuous Service during the two-year period commencing on the
date of a Change of Control (i)&#8239;by the Company, any of its Subsidiaries or the entity resulting from such Change of Control other
than for Cause (and not as a result of the Participant&rsquo;s disability or death), or (ii)&#8239;if applicable, by the Participant for
Good Reason.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Restatement
Date</U>&rdquo; has the meaning given such term in Section&#8239;1(a)&#8239;hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Restricted
Shares</U>&rdquo; means Shares granted or sold pursuant to Section&#8239;8 hereof as to which neither the substantial risk of forfeiture
nor the prohibition on transfers referred to in such Section&#8239;8 has expired.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Restricted
Share Unit</U>&rdquo; means a grant or sale of the right to receive Shares or cash at the end of a specified restricted period made pursuant
to Section&#8239;9 hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>SEC</U>&rdquo;
means the United States Securities and Exchange Commission, or any successor thereto.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Share</U>&rdquo;
means a share of common stock of the Company, par value $0.001 per share, or any security into which such Share may be changed by reason
of any transaction or event of the type referred to in Section&#8239;16 hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Stock
Appreciation Right</U>&rdquo; means a right granted pursuant to Section&#8239;7.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Stock
Option</U>&rdquo; means a right to purchase a Share granted to a Participant under the Plan in accordance with the terms and conditions
set forth in Section&#8239;6 hereof. Stock Options may be either Incentive Stock Options or Nonqualified Stock Options.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Subsidiary</U>&rdquo;
means: (i)&#8239;with respect to an Incentive Stock Option, a &ldquo;subsidiary corporation&rdquo; as defined under Section&#8239;424(f)&#8239;of
the Code; and (ii)&#8239;for all other purposes under the Plan, any corporation or other entity in which the Company owns, directly or
indirectly, a proprietary interest of more than fifty percent (50%) by reason of stock ownership or otherwise.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Substitute
Award</U>&rdquo; means an Award that is granted in assumption of, or in substitution or exchange for, an outstanding award previously
granted by an entity acquired directly or indirectly by the Company or with which the Company directly or indirectly combines.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>Ten
Percent Stockholder</U>&rdquo; shall mean any Participant who owns more than 10% of the combined voting power of all classes of stock
of the Company, within the meaning of Section&#8239;422 of the Code.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<U>2015
Plan</U>&rdquo; has the meaning given such term in Section&#8239;1(d)&#8239;hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Shares
Available Under the Plan.</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Shares
Available for Awards</U>. The maximum number of Shares that may be granted pursuant to Awards under the Plan shall be 4,100,000 Shares,
all of which may be issued pursuant to Incentive Stock Options. Shares issued or delivered pursuant to an Award may be authorized but
unissued Shares, treasury Shares, including Shares purchased in the open market, or a combination of the foregoing. The aggregate number
of Shares available for issuance or delivery under the Plan shall be subject to adjustment as provided in Section&#8239;16 hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 400 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Share
Counting</U>. Except as provided in Section&#8239;3(c)&#8239;hereof, the following Shares shall not count against, or shall be added back
to, the Share limit in Section&#8239;3(a)&#8239;hereof: (i)&#8239;Shares covered by an Award that expires or is forfeited, canceled, surrendered,
or otherwise terminated; (ii)&#8239;Shares covered by an award granted under the Prior Plan that, after stockholder approval of the Plan,
is forfeited, canceled, surrendered, or otherwise terminated; (iii)&#8239;Shares covered by an Award that is settled only in cash; and
(iv)&#8239;Substitute Awards (except as may be required by reason of the rules&#8239;and regulations of any stock exchange or other trading
market on which the Shares are listed). This Section&#8239;3(b)&#8239;shall apply to the number of Shares reserved and available for Incentive
Stock Options only to the extent consistent with applicable Code provisions relating to Incentive Stock Options under the Code.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Prohibition
of Liberal Share Recycling</U>. Notwithstanding Section&#8239;3(b), the following Shares subject to an Award shall not again be available
for grant as described above, regardless of whether those Shares are actually issued or delivered to the Participant: (i)&#8239;Shares
tendered in payment of the exercise price of a Stock Option; (ii)&#8239;Shares withheld by the Company or any Subsidiary to satisfy a
tax withholding obligation with respect to an Award; and (iii)&#8239;Shares that are repurchased by the Company with Stock Option proceeds.
Without limiting the foregoing, with respect to any Stock Appreciation Right that is settled in Shares, the full number of Shares subject
to the Award shall count against the number of Shares available for Awards under the Plan, regardless of the number of Shares used to
settle the Stock Appreciation Right upon exercise.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Limits
on Awards to Certain Directors</U>. Notwithstanding any other provision of the Plan to the contrary and except as otherwise provided in
this Section&#8239;3(d), the aggregate grant date fair value (determined as of the Date of Grant in accordance with FASB ASC Topic 718)
of all Awards granted to any Director (other than any Chair or Vice Chair of the Board) during any single fiscal year, together with any
cash compensation earned by such Director during such fiscal year, shall not exceed seven hundred fifty thousand dollars ($750,000). For
purposes of clarity, the limit set forth in this Section&#8239;3(d)&#8239;shall not apply to the compensation of any Chair or Vice Chair
of the Board.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Administration
of the Plan.</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>In
General</U>. The Plan shall be administered by the Committee. Except as otherwise provided by the Board, the Committee shall have full
and final authority in its discretion to take all actions determined by the Committee to be necessary in the administration of the Plan,
including, without limitation, discretion to: (i)&#8239;select Award recipients; (ii)&#8239;determine the sizes and types of Awards; (iii)&#8239;determine
the terms and conditions of Awards in a manner consistent with the Plan; (iv)&#8239;grant waivers of terms, conditions, restrictions and
limitations applicable to any Award, or (v)&#8239;accelerate the vesting or exercisability of any Award, in a manner consistent with the
Plan; (vi)&#8239;construe and interpret the Plan and any Award Agreement or other agreement or instrument entered into under the Plan;
(vii)&#8239;establish, amend, or waive rules&#8239;and regulations for the Plan&rsquo;s administration; and (viii)&#8239;take such other
action, not inconsistent with the terms of the Plan, as the Committee deems appropriate. To the extent permitted by Applicable Laws, the
Committee may, in its discretion, delegate to one or more Directors or Employees any of the Committee&rsquo;s authority under the Plan.
The acts of any such delegates shall be treated hereunder as acts of the Committee with respect to any matters so delegated.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Determinations</U>.
The Committee shall have no obligation to treat Participants or eligible Employees, Directors and Consultants uniformly, and the Committee
may make determinations under the Plan selectively among Participants who receive, or Employees, Directors or Consultants who are eligible
to receive, Awards (whether or not such Participants or eligible Employees, Directors or Consultants are similarly situated). All determinations
and decisions made by the Committee pursuant to the provisions of the Plan and all related orders and resolutions of the Committee shall
be final, conclusive and binding on all persons, including the Company, its Subsidiaries, stockholders, Directors, Consultants, Employees,
Participants, and their estates and beneficiaries.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Authority
of the Board</U>. The Board may reserve to itself any or all of the authority or responsibility of the Committee under the Plan or may
act as the administrator of the Plan for any and all purposes. To the extent the Board has reserved any such authority or responsibility,
or during any time that the Board is acting as administrator of the Plan, it shall have all the powers of the Committee hereunder, and
any reference herein to the Committee (other than in this Section&#8239;4(c)) shall include the Board. To the extent that any action of
the Board under the Plan conflicts with any action taken by the Committee, the action of the Board shall control. Without limiting the
foregoing, the Board specifically reserves the authority to approve and administer all Awards granted to Directors under the Plan, and
any references in the Plan to the &ldquo;Committee&rdquo; with respect to any such Awards shall be deemed to refer to the Board.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Eligibility
and Participation.&nbsp;</B>Each Employee, Director, and Consultant is eligible to participate in the Plan, upon selection by the Committee,
in the Committee&rsquo;s discretion. Subject to the provisions of the Plan, the Committee may, from time to time, select from all eligible
Employees, Directors and Consultants those to whom Awards shall be granted and shall determine, in its sole discretion, the nature of
any and all terms permissible by Applicable Laws and the amount of each Award. No Employee, Director or Consultant shall have the right
to be selected to receive an Award under the Plan, or, having been so selected, to be selected to receive future Awards.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Stock
Options.&nbsp;</B>Subject to the terms and conditions of the Plan, Stock Options may be granted to Participants in such number, and upon
such terms and conditions as shall be determined by the Committee in its sole discretion.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Award
Agreement</U>. Each Stock Option shall be evidenced by an Award Agreement that shall specify the exercise price, the term of the Stock
Option, the number of Shares covered by the Stock Option, the conditions upon which the Stock Option shall become vested and exercisable
and such other terms and conditions as the Committee shall determine and which are not inconsistent with the terms and conditions of the
Plan. The Award Agreement also shall specify whether the Stock Option is intended to be an Incentive Stock Option or a Nonqualified Stock
Option. No dividend equivalents may be granted with respect to the Shares underlying a Stock Option.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise
Price</U>. The exercise price per Share of a Stock Option shall be determined by the Committee at the time the Stock Option is granted
and shall be specified in the related Award Agreement;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that in no event shall the exercise
price per Share of any Stock Option (other than a Substitute Award) be less than one hundred percent (100%) of the Fair Market Value of
a Share on the Date of Grant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Term</U>.
The term of a Stock Option shall be determined by the Committee and set forth in the related Award Agreement;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that in no event shall the term of any Stock Option exceed ten (10)&#8239;years from its Date of Grant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercisability</U>.
Stock Options shall become vested and exercisable at such times and upon such terms and conditions as shall be determined by the Committee
and set forth in the related Award Agreement, subject to the terms and conditions of the Plan, including the minimum vesting provisions
of Section&#8239;12 hereof. Such terms and conditions may include, without limitation, the satisfaction of (i)&#8239;one or more Performance
Objectives, and (ii)&#8239;time-based vesting requirements.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise
of Stock Options</U>. Except as otherwise provided in the Plan or in a related Award Agreement, a Stock Option may be exercised for all
or any portion of the Shares for which it is then exercisable. A Stock Option shall be exercised by the delivery of a notice of exercise
to the Company or its designee in a form specified by the Company, which sets forth the number of Shares with respect to which the Stock
Option is to be exercised and full payment of the exercise price for such Shares. The exercise price of a Stock Option may be paid, in
the discretion of the Committee and as set forth in the applicable Award Agreement: (i)&#8239;in cash or its equivalent; (ii)&#8239;by
tendering (either by actual delivery or attestation) previously acquired Shares having an aggregate Fair Market Value at the time of exercise
equal to the aggregate exercise price; (iii)&#8239;by a cashless exercise (including by withholding Shares deliverable upon exercise or
through a broker-assisted arrangement to the extent permitted by Applicable Laws); (iv)&#8239;by a combination of the methods described
in the foregoing clauses (i), (ii)&#8239;and/or (iii); or (v)&#8239;through any other method approved by the Committee in its sole discretion.
As soon as practicable after receipt of the notification of exercise and full payment of the exercise price, the Company shall cause the
appropriate number of Shares to be issued to the Participant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Special
Rules&#8239;Applicable to Incentive Stock Options</U>. Notwithstanding any other provision in the Plan to the contrary:</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in; background-color: rgb(255, 255, 255)">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Incentive
Stock Options may be granted only to Employees. The terms and conditions of Incentive Stock Options shall be subject to and comply with
the requirements of Section&#8239;422 of the Code.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in; background-color: rgb(255, 255, 255)">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the extent that the aggregate Fair Market Value of the Shares (determined as of the Date of Grant) with respect to which an Incentive
Stock Option is exercisable for the first time by any Participant during any calendar year (under all plans of the Company and its Subsidiaries)
is greater than $100,000 (or such other amount specified in Section&#8239;422 of the Code), as calculated under Section&#8239;422 of the
Code, then the Stock Option shall be treated as a Nonqualified Stock Option.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in; background-color: rgb(255, 255, 255)">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
Incentive Stock Option shall be granted to any Participant who, on the Date of Grant, is a Ten Percent Stockholder, unless (A)&#8239;the
exercise price per Share of such Incentive Stock Option is at least one hundred and ten percent (110%) of the Fair Market Value of a Share
on the Date of Grant, and (B)&#8239;the term of such Incentive Stock Option shall not exceed five (5)&#8239;years from the Date of Grant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Stock
Appreciation Rights.&nbsp;</B>Subject to the terms and conditions of the Plan, Stock Appreciation Rights may be granted to Participants
in such number, and upon such terms and conditions, as shall be determined by the Committee in its sole discretion.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Award
Agreement</U>. Each Stock Appreciation Right shall be evidenced by an Award Agreement that shall specify the exercise price, the term
of the Stock Appreciation Right, the number of Shares covered by the Stock Appreciation Right, the conditions upon which the Stock Appreciation
Right shall become vested and exercisable and such other terms and conditions as the Committee shall determine and which are not inconsistent
with the terms and conditions of the Plan. No dividend equivalents may be granted with respect to the Shares underlying a Stock Appreciation
Right.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise
Price</U>. The exercise price per Share of a Stock Appreciation Right shall be determined by the Committee at the time the Stock Appreciation
Right is granted and shall be specified in the related Award Agreement;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that in no event shall
the exercise price per Share of any Stock Appreciation Right (other than a Substitute Award) be less than one hundred percent (100%) of
the Fair Market Value of a Share on the Date of Grant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Term</U>.
The term of a Stock Appreciation Right shall be determined by the Committee and set forth in the related Award Agreement;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that in no event shall the term of any Stock Appreciation Right exceed ten (10)&#8239;years from its Date of Grant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercisability
of Stock Appreciation Rights</U>. A Stock Appreciation Right shall become vested and exercisable at such times and upon such terms and
conditions as may be determined by the Committee and set forth in the related Award Agreement, subject to the terms and conditions of
the Plan, including the minimum vesting provisions of Section&#8239;12 hereof. Such terms and conditions may include, without limitation,
the satisfaction of (i)&#8239;one or more Performance Objectives, and (ii)&#8239;time-based vesting requirements.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise
of Stock Appreciation Rights</U>. Except as otherwise provided in the Plan or in a related Award Agreement, a Stock Appreciation Right
may be exercised for all or any portion of the Shares for which it is then exercisable. A Stock Appreciation Right shall be exercised
by the delivery of a notice of exercise to the Company or its designee in a form specified by the Company which sets forth the number
of Shares with respect to which the Stock Appreciation Right is to be exercised. Upon exercise, a Stock Appreciation Right shall entitle
a Participant to an amount equal to (i)&#8239;the excess of (A)&#8239;the Fair Market Value of a Share on the exercise date over (B)&#8239;the
exercise price per Share, multiplied by (ii)&#8239;the number of Shares with respect to which the Stock Appreciation Right is exercised.
A Stock Appreciation Right may be settled in whole Shares, cash, or a combination thereof, as specified by the Committee in the related
Award Agreement.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Restricted
Shares.&nbsp;</B>Subject to the terms and conditions of the Plan, Restricted Shares may be granted or sold to Participants in such number,
and upon such terms and conditions, as shall be determined by the Committee in its sole discretion.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Award
Agreement</U>. Each Restricted Share Award shall be evidenced by an Award Agreement that shall specify the number of Restricted Shares,
the restricted period(s)&#8239;applicable to the Restricted Shares, the conditions upon which the restrictions on the Restricted Shares
will lapse and such other terms and conditions as the Committee shall determine and which are not inconsistent with the terms and conditions
of the Plan.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Terms,
Conditions, and Restrictions</U>. The Committee shall impose such other terms, conditions and/or restrictions on any Restricted Shares
as it may deem advisable, including, without limitation, a requirement that the Participant pay a purchase price for each Restricted Share,
restrictions based on the achievement of specific Performance Objectives, time-based restrictions or holding requirements or sale restrictions
placed on the Shares by the Company upon vesting of such Restricted Shares subject to the terms and conditions of the Plan, including
the minimum vesting provisions of Section&#8239;12 hereof. Unless otherwise provided in the related Award Agreement or required by Applicable
Law, the restrictions imposed on Restricted Shares shall lapse upon the expiration or termination of the applicable restricted period
and the satisfaction of any other applicable terms and conditions.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Custody
of Certificates</U>. To the extent deemed appropriate by the Committee, the Company may retain any certificates representing Restricted
Shares in the Company&rsquo;s possession until such time as all terms, conditions, and/or restrictions applicable to such Shares have
been satisfied or lapse.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Rights
Associated with Restricted Shares during Restricted Period</U>. During any restricted period applicable to Restricted Shares: (i)&#8239;the
Restricted Shares may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated; (ii)&#8239;unless otherwise
provided in the related Award Agreement, the Participant shall be entitled to exercise any voting rights associated with such Restricted
Shares; and (iii)&#8239;the Participant shall be entitled to any dividends and other distributions paid with respect to such Restricted
Shares during the restricted period;&nbsp;<U>provided, however</U>, that any dividends with respect to unvested Restricted Shares shall
be accumulated or deemed reinvested in additional Restricted Shares (as determined by the Committee in its sole discretion and set forth
in the applicable Award Agreement), subject to the same terms and conditions as the original Award (including service-based vesting conditions
and any Performance Objectives) until such Award is earned and vested.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Restricted
Share Units.&nbsp;</B>Subject to the terms and conditions of the Plan, Restricted Share Units may be granted or sold to Participants in
such number, and upon such terms and conditions as shall be determined by the Committee in its sole discretion.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Award
Agreement</U>. Each Restricted Share Unit Award shall be evidenced by an Award Agreement that shall specify the number of units, the restricted
period(s)&#8239;applicable to the Restricted Share Units, the conditions upon which the restrictions on the Restricted Share Units will
lapse, the time and method of payment of the Restricted Share Units to the Participant, and such other terms and conditions as the Committee
shall determine and which are not inconsistent with the terms and conditions of the Plan, including the minimum vesting provisions of
Section&#8239;12 hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Terms,
Conditions, and Restrictions</U>. The Committee shall impose such other terms, conditions and/or restrictions on any Restricted Share
Units as it may deem advisable, including, without limitation, a requirement that the Participant pay a purchase price for each Restricted
Share Unit, restrictions based on the achievement of specific Performance Objectives or time-based restrictions or holding requirements.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Form&#8239;of
Settlement</U>. Restricted Share Units may be settled in whole Shares, cash, or a combination thereof, as specified by the Committee in
the related Award Agreement.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Other
Share-Based Awards.&nbsp;</B>Subject to the terms and conditions of the Plan, Other Share-Based Awards may be granted to Participants
in such number, and upon such terms and conditions, as shall be determined by the Committee in its sole discretion, subject to the terms
and conditions of the Plan, including the minimum vesting provisions of Section&#8239;12 hereof. Other Share-Based Awards are Awards that
are valued in whole or in part by reference to, or otherwise based on the Fair Market Value of, Shares, and shall be in such form as the
Committee shall determine, including, without limitation, unrestricted Shares (subject to the limitations of Section&#8239;12 hereof)
or time-based or performance-based units that are settled in Shares and/or cash.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Award
Agreement</U>. Each Other Share-Based Award shall be evidenced by an Award Agreement that shall specify the terms and conditions upon
which the Other Share-Based Award shall become vested, if applicable, the time and method of settlement, the form of settlement and such
other terms and conditions as the Committee shall determine and which are not inconsistent with the terms and conditions of the Plan.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Form&#8239;of
Settlement</U>. An Other Share-Based Award may be settled in whole Shares, cash, or a combination thereof, as specified by the Committee
in the related Award Agreement.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Dividend
Equivalents.&nbsp;</B>Awards granted under the Plan (other than Stock Options and Stock Appreciation Rights) may provide the Participant
with dividend equivalents, payable on a contingent basis and either in cash or in additional Shares, as determined by the Committee in
its sole discretion and set forth in the related Award Agreement;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that any dividend equivalents
with respect to an unvested Award shall be either accumulated in cash or deemed reinvested in additional Restricted Share Units, subject
to the same terms and conditions as the original Award (including service-based vesting conditions and the achievement of any Performance
Objectives) until such Award is earned and vested. Notwithstanding anything to the contrary herein, no dividend equivalents may be granted
under the Plan with respect to the Shares underlying any Stock Option or Stock Appreciation Right.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Minimum
Vesting Provisions.</B>&nbsp;Notwithstanding any other provision of the Plan to the contrary, Awards granted under the Plan shall not
become vested or exercisable in full any earlier than the first anniversary of the Date of Grant of the Award (excluding, for this purpose,
any (a)&#8239;Substitute Awards, and (b)&#8239;Awards to Directors that vest in full no later than the earlier of the first anniversary
of the date of grant or the next annual meeting of stockholders (provided that such vesting period is not less than 50 weeks after the
Date of Grant));&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that the Committee may grant Awards without regard to the foregoing minimum
vesting requirement with respect to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan
pursuant to Section&#8239;3(a)&#8239;hereof; and,&nbsp;<U>provided further</U>&nbsp;that the foregoing restriction does not apply to the
Committee&rsquo;s discretion to provide for accelerated exercisability or vesting of any Award, including in cases of retirement, death,
disability, other termination of employment or a Change of Control, by the terms of the Award Agreement or otherwise. For purposes of
clarity, an Award that vests or becomes exercisable in installments over a period that ends on or after the first anniversary of the Date
of Grant of the Award shall be considered to comply with the minimum vesting provisions of this Section&#8239;12.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Compliance
with Section&#8239;409A.&nbsp;</B>Awards granted under the Plan shall be designed and administered in such a manner that they are either
exempt from the application of, or comply with, the requirements of Section&#8239;409A of the Code. To the extent that the Committee determines
that any award granted under the Plan is subject to Section&#8239;409A of the Code, the Award Agreement shall incorporate the terms and
conditions necessary to avoid the imposition of an additional tax under Section&#8239;409A of the Code upon a Participant. Notwithstanding
any other provision of the Plan or any Award Agreement (unless the Award Agreement provides otherwise with specific reference to this
Section&#8239;13): (a)&#8239;an Award shall not be granted, deferred, accelerated, extended, paid out, settled, substituted, modified
or adjusted under the Plan in a manner that would result in the imposition of an additional tax under Section&#8239;409A of the Code upon
a Participant; and (b)&#8239;if an Award is subject to Section&#8239;409A of the Code, and if the Participant holding the award is a &ldquo;specified
employee&rdquo; (as defined in Section&#8239;409A of the Code, with such classification to be determined in accordance with the methodology
established by the Company), then, to the extent required to avoid the imposition of an additional tax under Section&#8239;409A of the
Code upon a Participant, no distribution or payment of any amount shall be made before the date that is six (6)&#8239;months following
the date of such Participant&rsquo;s &ldquo;separation from service&rdquo; (as defined in Section&#8239;409A of the Code) or, if earlier,
the date of the Participant&rsquo;s death. Although the Company intends to administer the Plan so that Awards will be exempt from, or
will comply with, the requirements of Section&#8239;409A of the Code, the Company does not warrant that any Award under the Plan will
qualify for favorable tax treatment under Section&#8239;409A of the Code, or any other provision of federal, state, local, or non-United
States law. The Company shall not be liable to any Participant for any tax, interest, or penalties the Participant might owe as a result
of the grant, holding, vesting, exercise, or payment of any Award under the Plan.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Performance
Objectives.</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>In
General</U>. As provided in the Plan, the vesting, exercisability, and/or payment of any Award may be conditioned upon the achievement
of one or more Performance Objectives (any such Award, a &ldquo;<U>Performance Award</U>&rdquo;). Any Performance Objectives shall be
based on the achievement of one or more criteria selected by the Committee, in its discretion, which may include, but shall not be limited
to, the following: (i)&#8239;revenue; (ii)&#8239; earnings before interest, taxes, depreciation and amortization, as adjusted (EBITDA
as adjusted); (iii)&#8239;income before income taxes and minority interests; (iv)&#8239;operating income; (v)&#8239; pre- or after-tax
income; (vi)&#8239;average accounts receivable; (vii)&#8239; cash flow; (viii)&#8239;cash flow per share; (ix)&#8239;net earnings; (x)&#8239;basic
or diluted earnings per share; (xi)&#8239;return on equity; (xii)&#8239;return on assets; (xiii)&#8239;return on capital; (xiv)&#8239;growth
in assets; (xv)&#8239;economic value added; (xvi)&#8239;share price performance; (xvii)&#8239;total stockholder return; (xviii)&#8239;improvement
or attainment of expense levels; (xix)&#8239;market share or market penetration; (xx)&#8239;business expansion, and/or acquisitions or
divestitures; or (xxi)&#8239;environmental, social or governance metrics.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Establishment
of Performance Objectives</U>. With respect to any Performance Award, the Committee shall establish in writing the Performance Objectives,
the performance period, and any formula for computing the payout of the Performance Awards. Such terms and conditions shall be established
in writing during the first ninety days of the applicable performance period (or by such other date as may be determined by the Committee,
in its discretion).</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Certification
of Performance</U>. Prior to payment, exercise, or vesting of any Performance Award, the Committee will certify in writing whether the
applicable Performance Objectives and other material terms imposed on such Performance Award have been satisfied, and, if they have, ascertain
the amount of the payout or vesting of the Performance Award.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Adjustments</U>.
If the Committee determines that a change in the Company&rsquo;s business, operations, corporate structure or capital structure, or in
the manner in which it conducts its business, or other events or circumstances render the Performance Objectives unsuitable, the Committee
may, in its discretion and without the consent of any Participant, adjust such Performance Objectives or the related level of achievement,
in whole or in part, as the Committee deems appropriate and equitable, including, without limitation, to exclude the effects of events
that are unusual in nature or infrequent in occurrence (as determined in accordance with applicable financial accounting standards), cumulative
effects of tax or accounting changes, discontinued operations, acquisitions, divestitures and material restructuring or asset impairment
charges.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Transferability.&nbsp;</B>Except
as otherwise determined by the Committee, no Award or dividend equivalents paid with respect to any Award shall be transferable by the
Participant except by will or the laws of descent and distribution; provided, that if so determined by the Committee, each Participant
may, in a manner established by the Board or the Committee, designate a beneficiary to exercise the rights of the Participant with respect
to any Award upon the death of the Participant and to receive Shares or other property issued or delivered under such Award. Except as
otherwise determined by the Committee, Stock Options and Stock Appreciation Rights will be exercisable during a Participant&rsquo;s lifetime
only by the Participant or, in the event of the Participant&rsquo;s legal incapacity to do so, by the Participant&rsquo;s guardian or
legal representative acting on behalf of the Participant in a fiduciary capacity under state law and/or court supervision.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Adjustments.&nbsp;</B>In
the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting Standards Codification Topic
718, or any successor thereto), such as a stock dividend, stock split, reverse stock split, spinoff, rights offering, or recapitalization
through a large, nonrecurring cash dividend, the Committee shall cause there to be an equitable adjustment in the number and kind of Shares
specified in Section&#8239;3 of the Plan and, with respect to outstanding Awards, in the number and kind of Shares subject to outstanding
Awards and the exercise price or other price of Shares subject to outstanding Awards, in each case, to prevent dilution or enlargement
of the rights of Participants. In the event of any other change in corporate capitalization, or in the event of a merger, consolidation,
liquidation, or similar transaction, the Committee may, in its sole discretion, cause there to be an equitable adjustment as described
in the foregoing sentence, to prevent dilution or enlargement of rights;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that, unless otherwise
determined by the Committee, the number of Shares subject to any Award shall always be rounded down to a whole number. Moreover, in the
event of any such transaction or event, the Committee, in its discretion, may provide in substitution for any or all outstanding Awards
such alternative consideration (including cash) as it, in good faith, may determine to be equitable in the circumstances, and may require
in connection therewith the surrender of all Awards so replaced. Notwithstanding the foregoing, the Committee shall not make any adjustment
pursuant to this Section&#8239;16 that would (a)&#8239;cause any Stock Option intended to qualify as an ISO to fail to so qualify, (b)&#8239;cause
an Award that is otherwise exempt from Section&#8239;409A of the Code to become subject to Section&#8239;409A, or (c)&#8239;cause an Award
that is subject to Section&#8239;409A of the Code to fail to satisfy the requirements of Section&#8239;409A. The determination of the
Committee as to the foregoing adjustments, if any, shall be conclusive and binding on all Participants and any other persons claiming
under or through any Participant.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Fractional
Shares.&nbsp;</B>The Company shall not be required to issue or deliver any fractional Shares pursuant to the Plan and, unless otherwise
provided by the Committee, fractional shares shall be settled in cash.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Withholding
Taxes.&nbsp;</B>To the extent required by Applicable Laws, a Participant shall be required to satisfy, in a manner satisfactory to the
Company or Subsidiary, as applicable, any withholding tax obligations that arise by reason of the exercise of a Stock Option or Stock
Appreciation Right, the vesting of or settlement of Shares under an Award, an election pursuant to Section&#8239;83(b)&#8239;of the Code
or otherwise with respect to an Award. The Company and its Subsidiaries shall not be required to issue or deliver Shares, make any payment,
or recognize the transfer or disposition of any Shares, until such withholding tax obligations are satisfied. The Committee may permit
or require these obligations to be satisfied by having the Company withhold a portion of the Shares that otherwise would be issued or
delivered to a Participant upon exercise of a Stock Option or Stock Appreciation Right or upon the vesting or settlement of an Award,
or by tendering Shares previously acquired, in each case having a value (as determined by the Company) equal to the amount required to
be withheld. Any such elections are subject to such conditions or procedures as may be established by the Committee and may be subject
to disapproval by the Committee. In no event will the value of the Shares to be withheld or tendered pursuant to this Section&#8239;18
to satisfy applicable withholding taxes exceed the amount of taxes required to be withheld based on the maximum statutory tax rates in
the applicable taxing jurisdictions.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Non-U.S.
Participants.&nbsp;</B>Without amending the Plan, the Committee may grant Awards to Participants who are foreign nationals, or who are
subject to Applicable Laws of one or more non-United States jurisdictions, on such terms and conditions different from those specified
in the Plan as may in the judgment of the Committee be necessary or desirable to foster and promote achievement of the purposes of the
Plan, and, in furtherance of such purposes, the Committee may approve such sub-plans, supplements to or amendments, modifications, restatements
or alternative versions of this Plan as may be necessary or advisable to comply with provisions of Applicable Laws of other countries
in which the Company or its Subsidiaries operate or have Employees or Consultants.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Compensation
Recovery Policy.&nbsp;</B>Any Award granted to a Participant shall be subject to forfeiture or repayment pursuant to the terms of the
Company&rsquo;s Compensation Recovery Policy as in effect from time to time (and any similar, supplemental, or successor policy).</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Change
of Control.</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>In
General</U>. The provisions of this Section&#8239;21 shall apply, notwithstanding any other provision of this Plan to the contrary, except
to the extent otherwise specifically provided in a Participant&rsquo;s Award Agreement.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Awards
that are Assumed</U>. To the extent outstanding Awards granted under this Plan are assumed, converted or replaced by the resulting entity
in the event of a Change of Control (or, if the Company is the resulting entity in the Change of Control, to the extent such Awards are
continued by the Company), then, except as otherwise provided in the applicable Award Agreement or in another written agreement with the
Participant, or in a Company severance plan applicable to the Participant: (i)&#8239;any outstanding Awards that are subject to Performance
Objectives shall be converted to service-vesting awards by the resulting entity, as if &ldquo;target&rdquo; performance had been achieved
as of the date of the Change of Control, and shall continue to vest based on the Participant&rsquo;s Continuous Service during the remaining
performance period or other period of required service, and (ii)&#8239;all other Awards shall continue to vest during the applicable vesting
period, if any. Notwithstanding the preceding sentence, if a Participant incurs a Qualified Termination, then upon such termination, all
outstanding Awards shall become fully vested and any such Awards that are Stock Options or Stock Appreciation Rights shall become fully
exercisable and shall remain exercisable for the full duration of their term.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Awards
that are not Assumed</U>. To the extent outstanding Awards granted under this Plan are not assumed, converted or replaced by the resulting
entity in connection with a Change of Control (or, if the Company is the resulting entity in the Change of Control, to the extent such
Awards are not continued by the Company), then effective immediately prior to the Change of Control, except as otherwise provided in the
applicable Award Agreement or in another written agreement with the Participant, or in a Company severance plan applicable to the Participant:
(i)&#8239;all outstanding Awards held by the Participant that may be exercised shall become fully exercisable and shall remain exercisable
for the full duration of their term, (ii)&#8239;all restrictions with respect to outstanding Awards shall lapse, with any specified Performance
Objectives with respect to outstanding Awards deemed to be satisfied at the &ldquo;target&rdquo; level, and (iii)&#8239;all outstanding
Awards shall become fully vested.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cancellation
Right</U>. The Committee may, in its sole discretion and without the consent of Participants, either by the terms of the Award Agreement
applicable to any Award or by resolution adopted prior to the occurrence of the Change of Control, provide that any outstanding Award
(or a portion thereof) shall, upon the occurrence of such Change of Control, be cancelled in exchange for a payment in cash or other property
(including shares of the resulting entity in connection with a Change of Control) in an amount equal to the excess, if any, of the Fair
Market Value of the Shares subject to the Award, over any exercise price related to the Award, which amount may be zero if the Fair Market
Value of a Share on the date of the Change of Control does not exceed the exercise price per Share of the applicable Awards.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Amendment,
Modification and Termination.</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>In
General</U>. The Board may at any time and from time to time, alter, amend, suspend or terminate the Plan in whole or in part;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that no alteration or amendment that requires stockholder approval in order for the Plan to comply with any rule&#8239;promulgated by
the SEC or any securities exchange on which Shares are listed or any other Applicable Laws shall be effective unless such amendment is
approved by the requisite vote of stockholders of the Company entitled to vote thereon within the time period required under such applicable
listing standard, rule&#8239;or law.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Adjustments
to Outstanding Awards</U>. The Committee may, in its sole discretion and without the consent of any Participant, at any time (i)&#8239;provide
that all or a portion of a Participant&rsquo;s Stock Options, Stock Appreciation Rights and other Awards in the nature of rights that
may be exercised shall become fully or partially exercisable; (ii)&#8239;provide that all or a part of the time-based vesting restrictions
on all or a portion of the outstanding Awards shall lapse, and/or that any Performance Objectives or other performance-based criteria
with respect to any Awards shall be deemed to be wholly or partially satisfied; or (iii)&#8239;waive any other limitation or requirement
under any such Award, in each case, as of such date as the Committee may, in its sole discretion, declare.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Prohibition
on Repricing Without Stockholder Approval</U>. Except for adjustments made pursuant to Sections 16 or 21 hereof, the Committee will not,
without the approval of the stockholders of the Company, authorize the amendment of any outstanding Stock Option or Stock Appreciation
Right to reduce the exercise price of such Award. No Stock Option or Stock Appreciation Right will be cancelled and replaced with an Award
having a lower exercise price, or for another Award, or for cash, without approval of the stockholders of the Company, except as provided
in Sections 16 or 21 hereof. Furthermore, no Stock Option or Stock Appreciation Right will provide for the payment, at the time of exercise,
of a cash bonus or grant or sale of another Award without further approval of the stockholders of the Company. This Section&#8239;22(c)&#8239;is
intended to prohibit the repricing of &ldquo;underwater&rdquo; Stock Options or Stock Appreciation Rights without stockholder approval
and will not be construed to prohibit the adjustments provided for in Sections 16 or 21 hereof.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Effect
on Outstanding Awards</U>. Notwithstanding any other provision of the Plan to the contrary (other than Sections 14(d), 16, 21, 22(b)&#8239;and
24(e)&#8239;hereof, which specifically do not require the consent of Participants), no termination, amendment, suspension, or modification
of the Plan or an Award Agreement shall adversely affect in any material way any Award previously granted under the Plan, without the
written consent of the Participant holding such Award;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that the Committee may modify an ISO
held by a Participant to disqualify such Stock Option from treatment as an &ldquo;incentive stock option&rdquo; under Section&#8239;422
of the Code without the Participant&rsquo;s consent.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Applicable
Laws.</B>&nbsp;The obligations of the Company with respect to Awards under the Plan shall be subject to all Applicable Laws and such approvals
by any governmental agencies as the Committee determines may be required. The Plan and each Award Agreement shall be governed by the laws
of the State of Delaware, excluding any conflicts or choice of law rule&#8239;or principle that might otherwise refer construction or
interpretation of the Plan to the substantive law of another jurisdiction.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Miscellaneous.</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Stock
Ownership Guidelines</U>. By accepting any Award under the Plan, each Participant shall thereby agree to comply with the terms and conditions
of any stock ownership guidelines the Company may maintain or establish, as the same may be applicable to the Participant from time to
time, including any applicable stock retention requirements thereunder.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Deferral
of Awards</U>. Except with respect to Stock Options, Stock Appreciation Rights and Restricted Shares, the Committee, in its discretion,
may permit Participants to elect to defer the issuance or delivery of Shares or the settlement of Awards in cash under the Plan pursuant
to such rules, procedures or programs as it may establish for purposes of the Plan. The Committee also may provide that deferred issuances
and settlements include the payment or crediting of dividend equivalents or interest on the deferral amounts. Any elections and deferrals
permitted under this provision shall comply with Section&#8239;409A of the Code, including setting forth the time and manner of the election
(including a compliant time and form of payment), the date on which the election is irrevocable, and whether the election can be changed
until the date it is irrevocable.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Right of Continued Service</U>. The Plan shall not confer upon any Participant any right with respect to continuance of employment or
other service with the Company or any Subsidiary, nor shall it interfere in any way with any right the Company or any Subsidiary would
otherwise have to terminate such Participant&rsquo;s employment or other service at any time. Awards granted under the Plan shall not
be considered a part of any Participant&rsquo;s normal or expected compensation or salary for any purposes, including, but not limited
to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards,
pension or retirement or welfare benefits or similar payments, and in no event shall any Award be considered as compensation for, or relating
in any way to, past services for the Company or any Subsidiary or affiliate.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Unfunded,
Unsecured Plan</U>. Neither a Participant nor any other person shall, by reason of participation in the Plan, acquire any right or title
to any assets, funds or property of the Company or any Subsidiary, including without limitation, any specific funds, assets or other property
which the Company or any Subsidiary may set aside in anticipation of any liability under the Plan. A Participant shall have only a contractual
right to an Award or the amounts, if any, payable under the Plan, unsecured by any assets of the Company or any Subsidiary, and nothing
contained in the Plan shall constitute a guarantee that the assets of the Company or any Subsidiary shall be sufficient to pay any benefits
to any person.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Severability</U>.
If any provision of the Plan or an Award Agreement is or becomes invalid, illegal or unenforceable in any jurisdiction, or would disqualify
the Plan or any Award under any Applicable Law, as determined by the Committee, such provision shall be construed or deemed amended or
limited in scope to conform to such Applicable Law or, in the discretion of the Committee, it shall be stricken and the remainder of the
Plan shall remain in full force and effect.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Acceptance
of Plan</U>. By accepting any benefit under the Plan, each Participant and each person claiming under or through any such Participant
shall be conclusively deemed to have indicated their acceptance and ratification of, and consent to, all of the terms and conditions of
the Plan, any Award Agreement and any action taken under the Plan by the Committee, the Board or the Company, in any case in accordance
with the terms and conditions of the Plan.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: rgb(255, 255, 255)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Successors</U>.
All obligations of the Company under the Plan and with respect to Awards granted hereunder shall be binding on any successor to the Company,
whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or other event, or a sale
or disposition of all or substantially all of the business and/or assets of the Company and references to the &ldquo;Company&rdquo; herein
and in any Award Agreements shall be deemed to refer to such successors.</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0px; background-color: rgb(255, 255, 255)">[END
OF DOCUMENT]</P>

<P STYLE="color: rgb(0, 0, 0); font: 400 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0pt 0; text-indent: 0px; background-color: rgb(255, 255, 255)">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>asth-20250611.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa6PObOdzZR+mYkxtmB+bVkafyck47Q+nybwlHIWYXQC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ASTH="http://apollomed.net/20250611" elementFormDefault="qualified" targetNamespace="http://apollomed.net/20250611">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://apollomed.net/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="asth-20250611_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="asth-20250611_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>asth-20250611_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>asth-20250611_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://apollomed.net/role/Cover" xlink:href="asth-20250611.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://apollomed.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 11,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ASTRANA HEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4472349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1668 S. Garfield Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alhambra<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">282-0288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASTH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2517571d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://apollomed.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asth-20250611.xsd</File>
    <File>asth-20250611_lab.xml</File>
    <File>asth-20250611_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2517571d1_8k.htm">tm2517571d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2517571d1_8k.htm": {
   "nsprefix": "ASTH",
   "nsuri": "http://apollomed.net/20250611",
   "dts": {
    "schema": {
     "local": [
      "asth-20250611.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "asth-20250611_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asth-20250611_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2517571d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://apollomed.net/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2517571d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2517571d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-25-058542-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-058542-xbrl.zip
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M9IC^.WGN/!&WB[W@835LA:2A# \5F[T^8(H8)(-\G%B7N*H;&M97R8QR=Z\
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M+5Y9<MG"O7OX\YMCOBS865!9(CGR69S62U,F^(% >@C.JHF4HRE)#FE*Y$3
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M1L7;5JW@ 3B@ED<)4[$[BM38N0]=]8+_*Z8%T@,2D^ J'U:=J?$")1+\;'+
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M^K'4\,HF''<K1+;I9Q)&>R:,_KPS8=1#*-*B:!R,",1"]!+LM&L&E#$N=G2
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MJI1^.GW[/#I]^R(ZJU9Y&GU[\MTA5WP"6\NIN#50L&TS/_? '3D.7[RXQ-7
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MQGQP[H)9[S82&,+$F,28S\@#B6TM-[*CP/K ZGO .B-W&@+CQ!^5%P%I<?L
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M*CX4XUT8F#JM<V(:ODI??**:\9M/C8E^3>-;6QMS9G8<A#"QPIJ';JW)0%\
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M_O!X]/>6RCZ,_J(G<>%67E88LC++:+PQ[M4*W1:.P.&53YV9ZT"&ZH&)23V
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MM9;L5$9#M$J"MF;O#T5]DM=LC\+#Z@LUN2V?HP;X^R^A!OC[J0;XWM+U?4V
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MP/ LS&0J+O2E,4&![J0F.OD&*?_A2<0!B2"T*OBV,;.FEKW&Z!(1L<$:B>T
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M,#(U,#8Q,5]L86(N>&UL4$L! A0#%     @ [H'+6K]6$797!P  UE<  !4
M             ( !B@X  &%S=&@M,C R-3 V,3%?<')E+GAM;%!+ 0(4 Q0
M   ( .Z!RUJ>B+='D!D  ">N   2              "  106  !T;3(U,3<U
M-S%D,5\X:RYH=&U02P$"% ,4    " #N@<M:CN[B_KM-  #Y&P( %@
M        @ '4+P  =&TR-3$W-3<Q9#%?97@Q,"TQ+FAT;5!+!08     !0 %
+ $D!  ##?0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>tm2517571d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asth-20250611.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2025-06-11</startDate>
            <endDate>2025-06-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-11" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-11" id="Fact000004">0001083446</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-11" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-11" id="Fact000010">2025-06-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-11" id="Fact000011">ASTRANA HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-11" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-11" id="Fact000013">001-37392</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-11" id="Fact000014">95-4472349</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-11" id="Fact000015">1668 S. Garfield Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-06-11" id="Fact000016">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-11" id="Fact000017">Alhambra</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-11" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-11" id="Fact000019">91801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-11" id="Fact000020">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-11" id="Fact000021">282-0288</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-11" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-11" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-11" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-11" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-06-11" id="Fact000026">Common     Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-06-11" id="Fact000027">ASTH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-06-11" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-11" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
